Repurposing clinically approved cephalosporins for tuberculosis therapy

While modern cephalosporins developed for broad spectrum antibacterial activities have never been pursued for tuberculosis (TB) therapy, we identified first generation cephalosporins having clinically relevant inhibitory concentrations, both alone and in synergistic drug combinations. Common chemica...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramón-García, Santiago, González del Río, Rubén, Villarejo, Angel Santos, Sweet, Gaye D., Cunningham, Fraser, Barros, David, Ballell, Lluís, Mendoza-Losana, Alfonso, Ferrer-Bazaga, Santiago, Thompson, Charles J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5039641/
https://www.ncbi.nlm.nih.gov/pubmed/27678056
http://dx.doi.org/10.1038/srep34293

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5039641/
https://www.ncbi.nlm.nih.gov/pubmed/27678056
http://dx.doi.org/10.1038/srep34293

Ejemplares similares